Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending December 8, 2003. The report is a notification of changes in directors' interests in the company's Ordinary Shares, specifically regarding transactions within the GlaxoSmithKline Employee Trust ("GSK Trust").
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a disclosure of equity transactions and does not contain financial performance data.
Material Changes
The filing details two specific transfers of Ordinary Shares from the GSK Trust to participants in the SmithKline Beecham Employee Share Option Plan 1991:
- December 4, 2003: Transfer of 1,000 Ordinary Shares.
- December 5, 2003: Transfer of 33,086 Ordinary Shares.
These transactions were advised to the company on December 5 and December 8, 2003, respectively.
Management Commentary and Risks
The filing notes that the GSK Trust is a discretionary trust where all current and former employees are potential beneficiaries. Consequently, two directors, Dr. J-P Garnier and Mr. J D Coombe, hold an interest in the shares held by the trust in the same capacity as other employees. No other risks, contingencies, or forward-looking guidance are provided in this text.
Investor Verification Points
- Verify the total number of shares transferred to the SmithKline Beecham Employee Share Option Plan 1991 during the reporting period (Total: 34,086 shares).
- Confirm the specific dates of notification to the company for each transaction (December 5 and December 8, 2003).
- Review the full annual report (Form 20-F) for comprehensive financial metrics, as this filing contains none.